Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Robert S. Bresalier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-9740-281X; OpenAlex author ID A5008320327; NIH RePORTER profile ID 1891491. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 5)
Trials
0
Grants
2
Labs led
1
Collaborators
20
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 grant · 2018: none · 2019: none · 2020: none · 2021: 1 paper, 1 grant · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 6

  1. CAR-Macrophage Cell Therapy: A New Era of Hope for Pancreatic Cancer. Last author DOI 10.1158/1078-0432.ccr-25-1201↗
  2. A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer. Last author DOI 10.1158/1078-0432.ccr-23-2098↗
  3. Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression. Last author DOI 10.1007/s10620-023-07931-3↗
  4. Vitamin D: Promises on the Horizon and Challenges Ahead for Fighting Pancreatic Cancer. Last author DOI 10.3390/cancers13112716↗
  5. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. Last author DOI 10.1371/journal.pone.0042699↗
  6. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Co-author DOI 10.1002/cncr.25803↗

Grants 2

  1. Integrated Signaling in Pancreatic Cancer Progression R01CA198090↗
  2. Molecular Mediators of Pancreatic Cancer Invasion and Progression R01CA172233↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liang Wang · 4 shared papers, 2021–2025 · strength 0.96
  2. Daoyan Wei · 4 shared papers, 2021–2025 · strength 0.96
  3. Xiangsheng Zuo · 4 shared papers, 2021–2025 · strength 0.96
  4. Keping Xie · 2 shared grants, 2017–2021 · strength 0.85
  5. Yi Liu · 2 shared papers, 2023–2025 · strength 0.49
  6. Xiling Shen · 1 shared paper, 2025 · strength 0.30
  7. Anirban Maitra · 1 shared paper, 2024 · strength 0.28
  8. Peiying Yang · 1 shared paper, 2023 · strength 0.18
  9. Huamin Wang · 1 shared paper, 2012 · strength 0.03
  10. Shumei Song · 1 shared paper, 2012 · strength 0.03
  11. Vijaya Ramachandran · 1 shared paper, 2012 · strength 0.03
  12. Baoan Ji · 1 shared paper, 2012 · strength 0.03
  13. Craig D. Logsdon · 1 shared paper, 2012 · strength 0.03
  14. Zhimin Tong · 1 shared paper, 2011 · strength 0.03
  15. Bharat Bhushan Aggarwal · 1 shared paper, 2011 · strength 0.03
  16. Subhankar Chakraborty · 1 shared paper, 2011 · strength 0.03
  17. Sendurai A. Mani · 1 shared paper, 2011 · strength 0.03
  18. Surinder K. Batra · 1 shared paper, 2011 · strength 0.03
  19. Sushovan Guha · 1 shared paper, 2011 · strength 0.03
  20. Sukhwinder Kaur · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.